open access

Vol 13, No 3 (2018)
Review Papers
Get Citation

Expert group consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy on the place of a standardized bergamot polyphenolic fraction in the treatment of dyslipidaemia and its other potential use in clinical practice

Marcin Barylski, Krzysztof J. Filipiak, Bogusław Okopień, Filip M. Szymański, Beata Wożakowska-Kapłon, Artur Mamcarz
DOI: 10.5603/FC.2018.0039
·
Folia Cardiologica 2018;13(3):222-235.

open access

Vol 13, No 3 (2018)
Review Papers

Abstract

Bergamot juice has a particularly high content and a unique composition of flavonoids. It is particularly rich in flavanones and flavones. Standardized bergamot polyphenolic fraction has the same polyphenol profile as in the juice, but flavonoids are over 200 times more concentrated. Many data show its brilliant performance in hyperlipidaemia and moderate hyperglycaemia. In addition, it has other beneficial pleiotropic properties. The following document contains the opinion of an expert group summarizing current knowledge on bergamot flavonoids and their possible use in selected populations of patients.

Abstract

Bergamot juice has a particularly high content and a unique composition of flavonoids. It is particularly rich in flavanones and flavones. Standardized bergamot polyphenolic fraction has the same polyphenol profile as in the juice, but flavonoids are over 200 times more concentrated. Many data show its brilliant performance in hyperlipidaemia and moderate hyperglycaemia. In addition, it has other beneficial pleiotropic properties. The following document contains the opinion of an expert group summarizing current knowledge on bergamot flavonoids and their possible use in selected populations of patients.

Get Citation

Keywords

standardized bergamot polyphenolic fraction, metabolic disorders, expert consensu

About this article
Title

Expert group consensus endorsed by the Polish Cardiac Society Working Group on Cardiovascular Pharmacotherapy on the place of a standardized bergamot polyphenolic fraction in the treatment of dyslipidaemia and its other potential use in clinical practice

Journal

Folia Cardiologica

Issue

Vol 13, No 3 (2018)

Pages

222-235

DOI

10.5603/FC.2018.0039

Bibliographic record

Folia Cardiologica 2018;13(3):222-235.

Keywords

standardized bergamot polyphenolic fraction
metabolic disorders
expert consensu

Authors

Marcin Barylski
Krzysztof J. Filipiak
Bogusław Okopień
Filip M. Szymański
Beata Wożakowska-Kapłon
Artur Mamcarz

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl